Genopathy
Gene-Disorder Association · Article
Gene
PHA2A
Pseudohypoaldosteronism Type II (Gene A)
Disorder
Pseudohypoaldosteronism, Type Iia
First reported 1970
Key publication · disorder Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction.Australasian annals of medicine · 1970
Manually curated
Association Review

In brief

The association between PHA2A (Pseudohypoaldosteronism Type II (Gene A)) and Pseudohypoaldosteronism, Type Iia is a manually-curated gene–disease association, supported by a single expert-curated source.

Sources 1
Clinical variants 0
Symptoms 7
Compounds 0
Trials 0
Publications 0
01
At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access
02
Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access
03
PHA2A

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access
04
Pseudohypoaldosteronism, Type Iia

The disorder

10 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access
05
Phenotype

Clinical features

5 clinical features

The disorder’s clinical features (HPO) grouped by body system, each with observed frequency and penetrance.

Request access
06
Provenance

References & sources

3 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access